Aligos Therapeutics Inc. (ALGS)
Market Closed
27 Jul, 20:00
$
4. 08
0
0%
$
25.25M Market Cap
- P/E Ratio
- Div Yield
212,999 Volume
-10.36 Eps
$ 4.08
Previous Close 
Want to track ALGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aligos Therapeutics Inc. (ALGS) Statistics
Valuation metrics
Market Cap 25.25M
Enterprise value -553.05K
Trailing P/E (ttm) -0.47
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 5.37
Price/Book (mrq) 1.34
Enterprise Value/Revenue -0.12
Enterprise Value/EBITDA 0.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 100.07K
Average volume (90 days) 122.69K
Price summary
52-Week low 3.98
52-Week high 13.69
Beta -
50-Day moving average 5.1
200-Day moving average 7.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 19 Aug 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -19.2%
Operating margin -20.33%
Operational effectiveness
Return on assets -1.4%
Return on equity -1.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -8.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 2.56%
Book value per share (mrq) 3.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
